Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Lupus Nephritis”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Early research (Phase 1)Looking for participantsNCT07123519
What this trial is testing

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Large-scale testing (Phase 3)Study completedNCT01328834
What this trial is testing

Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis

Who this might be right for
Nephritis, Lupus
Sun Yat-sen University 20
Early research (Phase 1)Looking for participantsNCT07104721
What this trial is testing

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Systemic Sclerosis (SSc)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117
What this trial is testing

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Novartis Pharmaceuticals 21
Early research (Phase 1)Looking for participantsNCT07109986
What this trial is testing

UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Nanjing IASO Biotechnology Co., Ltd. 21
Very early researchLooking for participantsNCT06653556
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Early research (Phase 1)Looking for participantsNCT06943937
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06581198
What this trial is testing

Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Novartis Pharmaceuticals 179
Very early researchUnknownNCT05085418
What this trial is testing

CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis

Who this might be right for
Immune NephritisAutoimmune DiseasesLupus Nephritis
Zhejiang University 9
Early research (Phase 1)Active Not RecruitingNCT06064929
What this trial is testing

Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Who this might be right for
Lupus Nephritis
HI-Bio, A Biogen Company 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07328581
What this trial is testing

BCMA-CD19 cCAR T for the Treatment of Refractory Lupus

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
iCell Gene Therapeutics 20
Very early researchLooking for participantsNCT06785519
What this trial is testing

CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis

Who this might be right for
Lupus Nephritis
He Huang 9
Testing effectiveness (Phase 2)WithdrawnNCT06153095
What this trial is testing

IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Lyell Immunopharma, Inc.
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Early research (Phase 1)Active Not RecruitingNCT06294236
What this trial is testing

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Who this might be right for
Lupus ErythematosusSystemic Lupus ErythematosusSLE (Systemic Lupus)+3 more
Sana Biotechnology 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07053800
What this trial is testing

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Autolus Limited 35
Testing effectiveness (Phase 2)Looking for participantsNCT06585514
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Beijing GoBroad Hospital 18
Early research (Phase 1)Looking for participantsNCT06984341
What this trial is testing

Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Genentech, Inc. 162
Testing effectiveness (Phase 2)Looking for participantsNCT06350110
What this trial is testing

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more
Essen Biotech 75
Testing effectiveness (Phase 2)UnknownNCT00698191
What this trial is testing

Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Refractory Systemic Lupus Erythematosus
Nanjing Medical University 20
Load More Results